(Q43294461)

18 November 2017

0 references

-765G>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case-control studies (English)

1 reference

18 November 2017

1 reference

Wei Zhu

1

1 reference

18 November 2017

Bing-bing Wei

series ordinal

2

1 reference

18 November 2017

Xia Shan

series ordinal

3

1 reference

18 November 2017

Ping Liu

series ordinal

4

1 reference

18 November 2017

language of work or name

1 reference

9 August 2009

1 reference

Molecular Biology Reports

18 November 2017

published in

1 reference

18 November 2017

volume

37

1 reference

18 November 2017

issue

1

1 reference

18 November 2017

page(s)

277-288

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-009-9685-1

18 November 2017

exact match

0 references

cites work

Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience

1 reference

https://api.crossref.org/works/10.1007%2FS11033-009-9685-1

-765G > C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-009-9685-1

Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-009-9685-1

Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-009-9685-1

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-009-9685-1

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-009-9685-1

Genotype Frequencies of Cyclooxygenease 2 (COX2) Rare Polymorphisms for Japanese with and without Colorectal Cancer

21 January 2018

1 reference

12 December 2020

Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer

1 reference

12 December 2020

Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese Health Study

1 reference

12 December 2020

Lung cancer and cyclooxygenase-2

1 reference

12 December 2020

Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies

1 reference

12 December 2020

Interaction of cyclooxygenase-2 variants and smoking in pancreatic cancer: a possible role of nucleophosmin.

1 reference

12 December 2020

Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA.

1 reference

12 December 2020

Cyclooxygenase-2 promotes prostate cancer progression

1 reference

12 December 2020

Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study

1 reference

12 December 2020

Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population

1 reference

12 December 2020

COX1 and COX2 polymorphisms and gastric cancer risk in a Polish population

1 reference

12 December 2020

Functional role of NF-IL6beta and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene

1 reference

12 December 2020

A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study

1 reference

12 December 2020

A comprehensive review of genetic association studies

1 reference

12 December 2020

Meta-analysis in clinical trials

1 reference

12 December 2020

Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2.

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status

1 reference

12 December 2020

Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response.

1 reference

12 December 2020

Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms.

1 reference

12 December 2020

Cyclooxygenase-2 and prostate carcinogenesis

1 reference

12 December 2020

Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer

1 reference

12 December 2020

Lack of association of the cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphism with risk of cervical cancer in Korean population.

1 reference

12 December 2020

Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk

1 reference

12 December 2020

COX-2 polymorphisms and the risk for head and neck cancer in white patients

1 reference

12 December 2020

Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma

1 reference

12 December 2020

Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes.

1 reference

12 December 2020

Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition.

1 reference

12 December 2020

Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer

1 reference

12 December 2020

Lack of Association between Polymorphisms in Inflammatory Genes and Lung Cancer Risk

1 reference

12 December 2020

A genetic polymorphism in prostaglandin synthase 2 (8473, T→C) and the risk of lung cancer

1 reference

12 December 2020

Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer

1 reference

12 December 2020

A common polymorphism in the 3'UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population

1 reference

12 December 2020

The role of cyclooxygenase-2 in prostate cancer

1 reference

12 December 2020

The 3'-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency

1 reference

12 December 2020

The power of the 3' UTR: translational control and development

1 reference

12 December 2020

Cyclooxygenase-2 in carcinogenesis of the gastrointestinal tract

1 reference

12 December 2020

Up-regulation of inflammatory signalings by areca nut extract and role of cyclooxygenase-2 -1195G>a polymorphism reveal risk of oral cancer.

1 reference

12 December 2020

Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China

1 reference

12 December 2020

COX-2 gene promoter haplotypes and prostate cancer risk

1 reference

12 December 2020

Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents.

1 reference

12 December 2020

Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

Cyclooxygenase 2 polymorphism and colorectal cancer: -765G>C variant modifies risk associated with smoking and body mass index

1 reference

12 December 2020

Genetic variation in the COX-2 gene and the association with prostate cancer risk

1 reference

12 December 2020

Expression of cyclooxygenase-2 in human lung carcinoma

1 reference

12 December 2020

Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion

1 reference

12 December 2020

Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.

1 reference

12 December 2020

Cyclooxygenase-2 and Inducible Nitric Oxide Synthase Gene Polymorphisms and Risk of Reflux Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma

1 reference

12 December 2020

Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey

1 reference

12 December 2020

Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism

1 reference

12 December 2020

Functional polymorphisms in the cyclooxygenase 2 (COX-2) gene and risk of breast cancer in a Chinese population

1 reference

12 December 2020

COX2 genetic variation, NSAIDs, and advanced prostate cancer risk

1 reference

12 December 2020

Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer.

1 reference

12 December 2020

10.1007/S11033-009-9685-1

Identifiers

DOI

1 reference

18 November 2017

1 reference